Teclistamab in relapsed/refractory Waldenstro m macroglobulinemia

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-07-16
DOI
https://doi.org/10.3324/haematol.2026.301159
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Teclistamab in relapsed/refractory Waldenstro m macroglobulinemia

Gabriela Kaščáková, Juraj Ďuraš, Katerina Karasova, Lucie Broskevičová et al.
Haematologica
Chronic Lymphocytic Leukemia Research
article

Teclistamab in relapsed/refractory Waldenstro m macroglobulinemia

Gabriela Kaščáková, Juraj Ďuraš, Katerina Karasova, Lucie Broskevičová, Tereza Ševčíková, Michal Kaščák, Martin Havel, Ondrej Venglár, Tereza Popková, Pavlína Kušnierová, Ludmila Muroňová, David Žihala, Eva Radova, Tereza Novakova, Jana Miha Lyova, Roman Hajek, Tomas Jelinek
article en

Abstract

No abstract available for this paper.
Haematologica
University of Ostrava (CZ), University Hospital Ostrava (CZ)
European Commission, Agentura Pro Zdravotnický Výzkum České Republiky
Zero hunger
Openalex Percentile: Top 9%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.